Hi! A quick reminder that our next press panel is tomorrow, brought to us by T2B's Media Minds Roundtable. Drew Armstrong (Endpoints News) and Angus Liu (Fierce Pharma) will join to talk about the stories they're following involving China’s growing role in global biopharma, and the issues they expect will shape coverage in 2027. From cross-border licensing and drug discovery to geopolitical tensions, investment, and supply chains, we'll dig into how journalists are navigating the competing...
1 day ago • 1 min read
Hi! Sometimes being successful as a communicator means … nothing actually happens. An emerging issue never becomes a crisis, a major organizational change unfolds without confusion, or a potentially problematic decision is reconsidered before it creates reputational risk. Our upcoming November Comm Convo will be a discussion about recognizing and articulating a part of our profession's value that often goes unnoticed – precisely because we've done our jobs well. We’ll address the challenge...
2 days ago • 1 min read
Hi! Your employer brand says a lot about your broader corporate reputation. But how closely does the story your company tells match what employees experience, what candidates discover, and what others say about working there? At our most recent Culture Connect Roundtable session, we explored what makes an employer brand credible, particularly during periods of growth, restructuring, and significant change. Carolin Groh (BioNTech), Tom Karim (Cytiva), Charlotte Marshall (Give & Get Employer...
3 days ago • 2 min read
Hi! “The press release is dead” is a popular refrain these days. But as AI changes how people search for and discover information, press releases are more than just a formality, and may offer a different kind of value: They now serve as source material for search engines, AI platforms, investors, patients, and anyone trying to understand a company's science, pipeline, or latest developments. At our most recent Digital & Social Media Roundtable session, our speakers explored what this means...
4 days ago • 2 min read
T2B Monthly | October 2026 Hi! I'd be remiss if I didn't mention as we close out October that this month marked T2B's third anniversary. In 2024, we proved the concept. In 2025, people showed they saw value in it. And this year, they've come back and have gotten even more involved (including you!)! Even better, I'm starting to hear stories about the difference T2B is making in people's lives. That means the most to me, and it's what motivates me to bring this community to even more...
7 days ago • 13 min read
Hi! As a reminder, our next Patient Advocacy & Engagement Roundtable event is tomorrow, October 29th. On the surface, patient advocacy can be associated with awareness campaigns, fundraising walks, and patient storytelling. But of course, the function extends well beyond those activities, influencing everything from research and clinical development to organizational strategy and decision-making. Tomorrow, our PA&E Roundtable members will challenge common assumptions about the function and...
9 days ago • 1 min read
Hi! We're headed back to London next month for the Jefferies Healthcare Conference and London Life Sciences Week! With an increasingly international audience gathering for the conference, we're looking forward to bringing together more of our global T2B community through two events focused on giving back and connecting with fellow biopharma communicators. Even if you're not making the trip, we'd love your help spreading the word! Please share these invitations with UK-based colleagues,...
10 days ago • 1 min read
Hi! Many of the decisions we’re asked to make have no clear or obvious correct answer. Taking a public position on an issue may reassure employees, but create political or commercial exposure. Staying silent may protect the company legally but undermine trust with patients or other stakeholders. And sometimes, the pressure to respond quickly doesn't leave much room to think through the longer-term implications. At this Friday's Comm Convo, we'll explore how communicators can help leadership...
11 days ago • 1 min read
Hi! China's role in global biopharma has changed dramatically over the past few years, evolving from a lower-cost manufacturing and research hub into a major source of innovation, drug development, and licensing activity. At the same time, geopolitical tensions and shifting U.S. policies have raised questions about cross-border partnerships, investment, intellectual property, and supply chains. At our upcoming Media Minds Roundtable press panel, we'll hear from Drew Armstrong (Endpoints) and...
14 days ago • 1 min read